Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

[Systematic PSA screening has been tried in Region Skåne. Balanced information gives chance for equal treatment according to a pilot project].

Bratt O, Lundgren R, Ahlgren G.

Lakartidningen. 2012 Sep 12-18;109(37):1610-2. Swedish. No abstract available.

PMID:
23077769
2.

Risks of PSA screening now better understood.

Peres J.

J Natl Cancer Inst. 2013 Nov 6;105(21):1590-2. doi: 10.1093/jnci/djt328. Epub 2013 Oct 18. No abstract available.

PMID:
24142893
3.

[Large part of Swedish men PSA tested for early prostatic cancer. Few aware of the disadvantages of the test].

Bratt O, Grenabo L.

Lakartidningen. 2010 Feb 17-23;107(7):432-5. Swedish. No abstract available.

PMID:
20384075
4.

[The PSA test does not hold for screening. Good--but not good enough].

Holmström B, Johansson M, Bratt O, Stattin P.

Lakartidningen. 2010 Feb 17-23;107(7):436, 438-9. Review. Swedish. No abstract available.

PMID:
20384076
5.

[The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].

Bratt O, Damber JE, Kärvinge C, Malm T, Hensjö LO, Hyttsten E.

Lakartidningen. 2008 Feb 20-26;105(8):524-8. Swedish. No abstract available.

PMID:
18363292
6.

Lung cancer screening gets risk-specific.

Peres J.

J Natl Cancer Inst. 2013 Jan 2;105(1):1-2. doi: 10.1093/jnci/djs631. Epub 2012 Dec 20. No abstract available.

PMID:
23257155
7.

The science and art of prostate cancer screening.

Yao SL, Lu-Yao GL.

J Natl Cancer Inst. 2011 Mar 16;103(6):450-1. doi: 10.1093/jnci/djr047. Epub 2011 Feb 24. No abstract available.

PMID:
21350220
8.

Screening by the prostate-specific antigen test: what do the patients know?

Diefenbach PN, Ganz PA, Pawlow AJ, Guthrie D.

J Cancer Educ. 1996 Spring;11(1):39-44.

PMID:
8777154
9.

Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?

Barry MJ, Mulley AJ Jr.

J Natl Cancer Inst. 2009 Mar 18;101(6):362-3. doi: 10.1093/jnci/djp028. Epub 2009 Mar 10. No abstract available.

PMID:
19276451
10.

[Utilization of screening and treatment of prostate cancer in 2011].

Tombal B.

Bull Mem Acad R Med Belg. 2011;166(3-4):170-6; discussion 177. French.

PMID:
22375496
11.

Should men be screened for prostate cancer?

Patel SM.

N C Med J. 1999 Sep-Oct;60(5):275-7. No abstract available.

PMID:
10495656
12.

[PSA based screening for prostatic cancer].

Johansen TE.

Tidsskr Nor Laegeforen. 2008 Nov 20;128(22):2612-4. Norwegian. No abstract available.

13.

Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.

Belpomme D, Irigaray P.

J Natl Cancer Inst. 2010 Apr 7;102(7):506-7. doi: 10.1093/jnci/djq045. Epub 2010 Feb 26. No abstract available.

PMID:
20190186
14.

[Austrian patient information materials on PSA-screening do not meet international evidence-based standards].

Strobelberger M, Kaminski A, Gartlehner G.

Wien Med Wochenschr. 2011 Feb;161(3-4):89-98. doi: 10.1007/s10354-010-0855-5. Epub 2011 Jan 25. German.

PMID:
21253813
15.

PSA measurement and prostate cancer--overdiagnosis and overtreatment?

Breidablik HJ, Meland E, Aakre KM, Førde OH.

Tidsskr Nor Laegeforen. 2013 Sep 3;133(16):1711-6. doi: 10.4045/tidsskr.13.0023. English, Norwegian.

16.

PSA as a screening test for prostate cancer.

Crawford ED, DeAntoni EP.

Urol Clin North Am. 1993 Nov;20(4):637-46. Review.

PMID:
7505971
17.

PSA doubling time as a predictive factor on repeat biopsy for detection of prostate cancer.

Shimbo M, Tomioka S, Sasaki M, Shima T, Suzuki N, Murakami S, Nakatsu H, Shimazaki J.

Jpn J Clin Oncol. 2009 Nov;39(11):727-31. doi: 10.1093/jjco/hyp091. Epub 2009 Aug 12.

PMID:
19674994
18.

PSA-based screening for prostate cancer. Too many adverse effects.

[No authors listed]

Prescrire Int. 2012 Sep;21(130):215-7. Review.

PMID:
23016259
19.

States renewing attention to prostate cancer.

Rossiter C.

NCSL Legisbrief. 2012 Sep;20(36):1-2. No abstract available.

PMID:
23072022
20.

[Mass screening for prostate cancer is the best approach to early diagnosis and treatment of prostate cancer].

Zhao XJ, Kong XB, Wang WH.

Zhonghua Nan Ke Xue. 2003 Nov;9(8):563-5, 568. Chinese.

PMID:
14689882

Supplemental Content

Support Center